| For: | Yu B, Li XR, Zhang XM. Mesenchymal stem cell-derived extracellular vesicles as a new therapeutic strategy for ocular diseases. World J Stem Cells 2020; 12(3): 178-187 [PMID: 32266050 DOI: 10.4252/wjsc.v12.i3.178] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v12/i3/178.htm |
| Number | Citing Articles |
| 1 |
Dany Perocheau, Loukia Touramanidou, Sonam Gurung, Paul Gissen, Julien Baruteau. Clinical applications for exosomes: Are we there yet?. British Journal of Pharmacology 2021; 178(12) doi: 10.1111/bph.15432
|
| 2 |
Faezeh Shekari, Morteza Abyadeh, Anna Meyfour, Mehdi Mirzaei, Nitin Chitranshi, Vivek Gupta, Stuart L. Graham, Ghasem Hosseini Salekdeh. Extracellular vesicles as reconfigurable therapeutics for eye diseases: Promises and hurdles. Progress in Neurobiology 2023; 225 doi: 10.1016/j.pneurobio.2023.102437
|
| 3 |
Kevin Y. Wu, Hamza Ahmad, Grace Lin, Marjorie Carbonneau, Simon D. Tran. Mesenchymal Stem Cell-Derived Exosomes in Ophthalmology: A Comprehensive Review. Pharmaceutics 2023; 15(4) doi: 10.3390/pharmaceutics15041167
|
| 4 |
Isai Mathivanan, Enzmann Volker, Keerthana Thyagarajan, Anitha Thirugnanasambantham Sivasubramanian, Kamaraj Raju, Annadurai Thangaraj. Age-Related Macular Degeneration: Therapeutic Strategies Based on Stem Cells. Stem Cell Reviews and Reports 2025; 21(7) doi: 10.1007/s12015-025-10917-5
|
| 5 |
Eva Ramsay, Tatu Lajunen, Madhushree Bhattacharya, Mika Reinisalo, Kirsi Rilla, Heidi Kidron, Tetsuya Terasaki, Arto Urtti. Selective drug delivery to the retinal cells: Biological barriers and avenues. Journal of Controlled Release 2023; 361 doi: 10.1016/j.jconrel.2023.07.028
|
| 6 |
Nagendra Verma, Swati Arora, Anurag Kumar Singh, Jahangir Ahmed. Unlocking the potential of exosomes ‘extracellular vesicles’: drug delivery advancements and therapeutics in ocular diseases. RSC Pharmaceutics 2025; 2(6) doi: 10.1039/D5PM00097A
|
| 7 |
Wei Hu, Xiang Song, Haibo Yu, Jingyu Sun, Yong Zhao. Therapeutic Potentials of Extracellular Vesicles for the Treatment of Diabetes and Diabetic Complications. International Journal of Molecular Sciences 2020; 21(14) doi: 10.3390/ijms21145163
|
| 8 |
Yvette Wooff. Locked and loaded: targeting extracellular vesicles to preserve sight. Communications Biology 2023; 6(1) doi: 10.1038/s42003-023-05672-7
|
| 9 |
Khan Sharun, S. Amitha Banu, B. Alifsha, Laith Abualigah, A. M. Pawde, Kuldeep Dhama, Amar Pal. Mesenchymal stem cell therapy in veterinary ophthalmology: clinical evidence and prospects. Veterinary Research Communications 2024; 48(6) doi: 10.1007/s11259-024-10522-w
|
| 10 |
Carmen Gutierrez‐Millan, Clara Calvo Díaz, José M. Lanao, Clara I. Colino. Advances in Exosomes‐Based Drug Delivery Systems. Macromolecular Bioscience 2021; 21(1) doi: 10.1002/mabi.202000269
|
| 11 |
Shangli Ji, Yanfang Peng, Jian Liu, Pang Xu, Shibo Tang. Human adipose tissue-derived stem cell extracellular vesicles attenuate ocular hypertension-induced retinal ganglion cell damage by inhibiting microglia- TLR4/MAPK/NF-κB proinflammatory cascade signaling. Acta Neuropathologica Communications 2024; 12(1) doi: 10.1186/s40478-024-01753-8
|
| 12 |
Ali Rajool Dezfuly, Azadeh Safaee, Hossein Salehi. Therapeutic effects of mesenchymal stem cells-derived extracellular vesicles’ miRNAs on retinal regeneration: a review. Stem Cell Research & Therapy 2021; 12(1) doi: 10.1186/s13287-021-02588-z
|
| 13 |
Hanieh Hadady, Fereshteh Karamali, Fatemeh Ejeian, Sareh Soroushzadeh, Mohammad Hossein Nasr-Esfahani. Potential neuroprotective effect of stem cells from apical papilla derived extracellular vesicles enriched by lab-on-chip approach during retinal degeneration. Cellular and Molecular Life Sciences 2022; 79(7) doi: 10.1007/s00018-022-04375-2
|
| 14 |
Iwona Rykowska, Iwona Nowak, Rafał Nowak, Ola Michałkiewicz. Biodegradable Contact Lenses for Targeted Ocular Drug Delivery: Recent Advances, Clinical Applications, and Translational Perspectives. Molecules 2025; 30(12) doi: 10.3390/molecules30122542
|
| 15 |
Milad Ahani-Nahayati, Vahid Niazi, Alireza Moradi, Bahareh Pourjabbar , Reza Roozafzoon, Alireza Baradaran-Rafii, Saeed Heidari Keshel. Cell-based Therapy for Ocular Disorders: A Promising Frontier. Current Stem Cell Research & Therapy 2022; 17(2) doi: 10.2174/1574888X16666210622124555
|
| 16 |
Laura García-Posadas, Ismael Romero-Castillo, Kieran Brennan, Margaret M. Mc Gee, Alfonso Blanco-Fernández, Yolanda Diebold. Isolation and Characterization of Human Conjunctival Mesenchymal Stromal Cells and Their Extracellular Vesicles. Investigative Opthalmology & Visual Science 2023; 64(12) doi: 10.1167/iovs.64.12.38
|
| 17 |
Yasunari Matsuzaka, Ryu Yashiro. Current Strategies and Therapeutic Applications of Mesenchymal Stem Cell-Based Drug Delivery. Pharmaceuticals 2024; 17(6) doi: 10.3390/ph17060707
|
| 18 |
Alireza Nouralishahi, Navid Fazlinejad, Renzon Daniel Cosme Pecho, Haider Kamil Zaidan, Hadis Kheradjoo, Ali H. Amin, Saman Mohammadzadehsaliani. Pathological role of inflammation in ocular disease progress and its targeting by mesenchymal stem cells (MSCs) and their exosome; current status and prospect. Pathology - Research and Practice 2023; 248 doi: 10.1016/j.prp.2023.154619
|
| 19 |
Megan M. Allyn, Richard H. Luo, Elle B. Hellwarth, Katelyn E. Swindle-Reilly. Considerations for Polymers Used in Ocular Drug Delivery. Frontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.787644
|
| 20 |
W. Li, L. Jin, Y. Cui, A. Nie, N. Xie, G. Liang. Bone marrow mesenchymal stem cells-induced exosomal microRNA-486-3p protects against diabetic retinopathy through TLR4/NF-κB axis repression. Journal of Endocrinological Investigation 2021; 44(6) doi: 10.1007/s40618-020-01405-3
|
| 21 |
Jia Liu, Feng Jiang, Yu Jiang, Yicheng Wang, Zelin Li, Xuefeng Shi, Yanping Zhu, Hongbo Wang, Zhuhong Zhang. Roles of Exosomes in Ocular Diseases. International Journal of Nanomedicine 2020; doi: 10.2147/IJN.S277190
|
| 22 |
Tian-Qi Duan, Zhao-Lin Gao, Ai-Xiang Luo, Dan Chen, Jian-Bin Tong, Ju-Fang Huang. Adipose mesenchymal stem cell-derived extracellular vesicles reduce glutamate-induced excitotoxicity in the retina. Neural Regeneration Research 2023; 18(10) doi: 10.4103/1673-5374.369123
|
| 23 |
Hamed Massoumi, Sohil Amin, Mohammad Soleimani, Bita Momenaei, Mohammad Javad Ashraf, Victor H. Guaiquil, Peiman Hematti, Mark I. Rosenblatt, Ali R. Djalilian, Elmira Jalilian. Extracellular-Vesicle-Based Therapeutics in Neuro-Ophthalmic Disorders. International Journal of Molecular Sciences 2023; 24(10) doi: 10.3390/ijms24109006
|
| 24 |
Chen Jin, Guoxing Xu. Study on the Promotion of hADSCs Migration and Chemotaxis by SDF-1. Asia-Pacific Journal of Ophthalmology 2023; 12(3) doi: 10.1097/APO.0000000000000613
|
| 25 |
Shisi Ma, Xiao Liu, Jiayang Yin, Lili Hao, Yuyao Diao, Jingxiang Zhong. Exosomes and autophagy in ocular surface and retinal diseases: new insights into pathophysiology and treatment. Stem Cell Research & Therapy 2022; 13(1) doi: 10.1186/s13287-022-02854-8
|
| 26 |
Kyungmin Koh, Mira Park, Eun Soo Bae, Van-An Duong, Jong-Moon Park, Hookeun Lee, Helen Lew. UBA2 activates Wnt/β-catenin signaling pathway during protection of R28 retinal precursor cells from hypoxia by extracellular vesicles derived from placental mesenchymal stem cells. Stem Cell Research & Therapy 2020; 11(1) doi: 10.1186/s13287-020-01943-w
|
| 27 |
Raffaele Nuzzi, Paolo Caselgrandi, Alessandro Vercelli, Stefania Cantore. Effect of Mesenchymal Stem Cell-Derived Exosomes on Retinal Injury: A Review of Current Findings. Stem Cells International 2020; 2020 doi: 10.1155/2020/8883616
|
| 28 |
Peggy Arthur, Sangeetha Kandoi, Li Sun, Anil Kalvala, Shallu Kutlehria, Santanu Bhattacharya, Tanmay Kulkarni, Ramesh Nimma, Yan Li, Deepak A. Lamba, Mandip Singh. Biophysical, Molecular and Proteomic Profiling of Human Retinal Organoid-Derived Exosomes. Pharmaceutical Research 2023; 40(4) doi: 10.1007/s11095-022-03350-7
|
| 29 |
Mohsen Akbaribazm. Exploring the Regenerative Potential of Stem Cells for Treating Eye Diseases: A Review of the New Findings. OBM Genetics 2024; 8(01) doi: 10.21926/obm.genet.2401212
|
| 30 |
Baodong Zhang, Shusong Gao, Shibo Liu, Xuewu Gong, Jing Wu, Yu Zhang, Li Ma, Lijie Sheng. Regenerative mechanisms of stem cells and their clinical applications for degenerative eye diseases. Journal of Research in Medical Sciences 2024; 29(1) doi: 10.4103/jrms.jrms_358_23
|
| 31 |
Gabriele Saccu, Valeria Menchise, Chiara Gai, Marina Bertolin, Stefano Ferrari, Cristina Giordano, Marta Manco, Walter Dastrù, Emanuela Tolosano, Benedetta Bussolati, Enzo Calautti, Giovanni Camussi, Fiorella Altruda, Sharmila Fagoonee. Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Promote Corneal Wound Repair by Regulating Inflammation and Angiogenesis. Cells 2022; 11(23) doi: 10.3390/cells11233892
|
| 32 |
Ahmed Lotfy, Noha M. AboQuella, Hongjun Wang. Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials. Stem Cell Research & Therapy 2023; 14(1) doi: 10.1186/s13287-023-03287-7
|
| 33 |
Vladimir Holan, Eliska Javorkova, Barbora Hermankova, Pavel Rossner. Combined Therapy Using Mesenchymal Stem Cells and Metal Nanoparticles: Perspectives for Ocular Injuries and Diseases. International Journal of Nanomedicine 2025; doi: 10.2147/IJN.S527928
|
| 34 |
Elham Sharif, Nader Hashemi, Fatemeh Eskandari, Forough Shams, Mahmood Rekabgardan. Exosome Engineering: The Promise and Peril of Targeted Delivery for Treating Ocular Diseases. Tissue and Cell 2026; doi: 10.1016/j.tice.2026.103664
|
| 35 |
Ashish Ranjan Dwivedi, Yogesh Murti, Pramod Rawat, Shriya Mahajan, Harsimrat Kandhari, Gaurav Joshi, Bhupinder Kumar. Exploring the Insights on Exosomes and their Utility in Treating Ophthalmic Disease: Delving into the Clinical Approval and Present Trials. Current Drug Delivery 2026; 23(1) doi: 10.2174/0115672018324046240905134931
|
| 36 |
Filippo Bonelli, Seyedmohammad Moosavizadeh, Elisa Fasolo, Alessia Di Nella, Vanessa Barbaro, Ilaria Zorzi, Mauro Krampera, Jana D'Amato Tóthová, Diego Ponzin, Thomas Ritter, Stefano Ferrari, Umberto Rodella. Development and optimization of an ex vivo model of corneal epithelium damage with 1-heptanol: Investigating the influence of donor clinical parameters and MSC-sEV treatment on healing capacity. The Ocular Surface 2025; 36 doi: 10.1016/j.jtos.2025.02.002
|
| 37 |
Azam Habibi, Zeinab Zarei-Behjani, Kimia Falamarzi, Mahdi Malekpour, Fatemeh Ebrahimi, Masood Soleimani, Mahmood Nejabat, Amir Khosravi, Zahra Moayedfard, Sara Pakbaz, Niloofar Dehdari Ebrahimi, Negar Azarpira. Extracellular vesicles as a new horizon in the diagnosis and treatment of inflammatory eye diseases: A narrative review of the literature. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1097456
|
| 38 |
Bo Yu, Kang Wang, Huijie Hao, Yan Liu, Yi Yue, Xiaorong Li, Xiaoli Xing, Xiaomin Zhang. Small extracellular vesicles derived from microRNA-22-3p-overexpressing mesenchymal stem cells protect retinal ganglion cells by regulating MAPK pathway. Communications Biology 2024; 7(1) doi: 10.1038/s42003-024-06511-z
|
| 39 |
Madalina Radu, Daniel Constantin Brănișteanu, Ruxandra Angela Pirvulescu, Otilia Maria Dumitrescu, Mihai Alexandru Ionescu, Mihail Zemba. Exploring Stem-Cell-Based Therapies for Retinal Regeneration. Life 2024; 14(6) doi: 10.3390/life14060668
|
| 40 |
Xingru Peng, Tingting Zhang, Rui Liu, Xin Jin. Potential in exosome-based targeted nano-drugs and delivery vehicles for posterior ocular disease treatment: from barriers to therapeutic application. Molecular and Cellular Biochemistry 2024; 479(6) doi: 10.1007/s11010-023-04798-w
|
| 41 |
Oytun Okan Şenel, İrem Ergin, Sumeyye Sainkaplan. Limbal stem cell deficiency in cats: Etiology, clinical manifestations, diagnosis and management. Ankara Üniversitesi Veteriner Fakültesi Dergisi 2025; 72(1) doi: 10.33988/auvfd.1443443
|
| 42 |
José Javier López-Cano, Miriam Ana González-Cela-Casamayor, Vanessa Andrés-Guerrero, Rocío Herrero-Vanrell, Irene Teresa Molina-Martínez. Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection. Expert Opinion on Drug Delivery 2021; 18(7) doi: 10.1080/17425247.2021.1872542
|
| 43 |
Lian Liu, Chunlan Liang, Wei Fan, Jingxiang Zhong. Effect of human umbilical cord mesenchymal stem cell exosomes on aerobic metabolism of human retinal pigment epithelial cells. International Ophthalmology 2022; 43(4) doi: 10.1007/s10792-022-02530-z
|
| 44 |
Mei Yang, Guang-hua Peng. The molecular mechanism of human stem cell-derived extracellular vesicles in retinal repair and regeneration. Stem Cell Research & Therapy 2023; 14(1) doi: 10.1186/s13287-023-03319-2
|
| 45 |
Barbora Hermankova, Eliska Javorkova, Katerina Palacka, Vladimir Holan. Perspectives and Limitations of Mesenchymal Stem Cell–Based Therapy for Corneal Injuries and Retinal Diseases. Cell Transplantation 2025; 34 doi: 10.1177/09636897241312798
|
| 46 |
Zijian Liu, Ruiyang Yin, Jiaxing Tian. Extracellular vesicles: mechanisms and prospects in type 2 diabetes and its complications. Frontiers in Endocrinology 2025; 15 doi: 10.3389/fendo.2024.1521281
|
| 47 |
Flor Negrete-Diaz, Sofia Martinez-Rodriguez, Atocha Guedan-Duran, Andrea Romero-Lopez, Fivos Panetsos. MSC secretomes as a cell-free therapeutic platform: Molecular heterogeneity, disease-specific bioactivity, delivery strategies, and regulatory translation across six major disease areas. Pharmacological Research 2026; 230 doi: 10.1016/j.phrs.2026.108245
|